Back to top

Image: Bigstock

Civitas Solutions (CIVI) Acquires Country Life Care Center

Read MoreHide Full Article

Civitas Solutions, Inc. (CIVI - Free Report) recently announced the acquisition of Country Life Care Center, a rehabilitation and post-acute care facility located in Riverton, UT.

Stock Performance

Civitas Solutions has had an unimpressive run on the bourse over the last three months. The company lost roughly 2.54% versus the Zacks categorized Medical services sub industry’s gain of almost 7.45%. The current level also compares unfavorably with the S&P 500’s return of 3.97% over the same time frame.

The estimate revision trend seems unfavorable for the stock at this moment. No estimates moved up in the last 60 days while there were three downward movements, which is a concern for investors. Notably, the current-year estimates for the stock stands at 70 cents per share.

Coming back to the news, we feel that the acquisition is a smart move on the part of the company. With a total of 36 private living spaces, Country Life specializes in providing short-  and long-term medical care for individuals who have experienced catastrophic injury or illness, including traumatic brain and spinal cord injuries. Country Life generated revenues of approximately $9 million in the last completed financial year.

Civitas Solutions is a leading national provider of home and community-based health and human services to individuals with intellectual, developmental, physical or behavioral disabilities and other special needs.

Zacks Rank & Stocks to Consider

Civitas Solutions has a Zacks Rank #4 (Sell).

A few better-ranked stocks in the broader medical sector are Inogen Inc. (INGN - Free Report) , Mesa Laboratories, Inc. (MLAB - Free Report) and Edap Tms S.a. (EDAP - Free Report) . Notably, all the stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Inogen has a long-term expected earnings growth rate of 17.50%. Notably, the stock represents an impressive one-year return of 100%.

Mesa Laboratories has a positive earnings surprise of 2.84% over the last four quarters. Notably, the stock represents an impressive one-year return of 16.7%.

Edap Tms represents a stellar one-year return of 2.2% for the last three months. The company provided a solid earnings surprise of 533.3% in the last reported quarter.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>Today's Stocks from Zacks' Hottest Strategies It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively. And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>
 

Published in